AFRIN

This brand name is authorized in Brazil, Ecuador, Estonia, Hong Kong SAR China, Lithuania, Mexico, Poland, Romania, Singapore.

Active ingredients

The drug AFRIN contains one active pharmaceutical ingredient (API):

1
UNII K89MJ0S5VY - OXYMETAZOLINE HYDROCHLORIDE
 

Oximetazoline is an imidazoline derivative. It exhibits sympathomimetic activity and specifically stimulates the α-adrenergic receptors of the sympathetic system. When administered topically to the nose it causes vasoconstriction of the expansed arterioles of the mucosal nose and a concurrent reduction in blood flow. It also reduces the hypersecretion of the nasal mucosa, ultimately contributing to the decongestion of the nasal mucosa.

 
Read more about Oxymetazoline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R01AA05 Oxymetazoline R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AA Sympathomimetics, plain
Discover more medicines within R01AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 525516020019117, 525516020019217, 525516020019317, 538917110027917, 538917110028017, 538918020028517
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 3249-MEE-0518, 3250-MEE-0518, 364440213, 4852-MEE-1019, 7066-MEE-0222, H6950913
EE Ravimiamet 1471249, 1471250, 1471283, 1471294
HK Department of Health Drug Office 01416
LT Valstybinė vaistų kontrolės tarnyba 1054106, 1054107, 1054108, 1054109
MX Comisión Federal para la Protección contra Riesgos Sanitarios 64245
PL Rejestru Produktów Leczniczych 100003225, 100157537, 100272920, 100272942, 100394214
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W63202001, W63203001, W63204001
SG Health Sciences Authority 02656P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.